Last €1.36 EUR
Change Today -0.01 / -0.73%
Volume 125.2K
AGFB On Other Exchanges
Symbol
Exchange
EN Brussels
OTC US
OTC US
Xetra
As of 11:37 AM 05/17/13 All times are local (Market data is delayed by at least 15 minutes).

agfa-gevaert nv (AGFB) Snapshot

Open
€1.37
Previous Close
€1.37
Day High
€1.38
Day Low
€1.36
52 Week High
01/21/13 - €1.73
52 Week Low
06/14/12 - €1.18
Market Cap
228.1M
Average Volume 10 Days
243.3K
EPS TTM
€-0.16
Shares Outstanding
167.8M
EX-Date
04/29/10
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for AGFA-GEVAERT NV (AGFB)

Related News

No related news articles were found.

agfa-gevaert nv (AGFB) Related Businessweek News

No Related Businessweek News Found

agfa-gevaert nv (AGFB) Details

Agfa-Gevaert NV develops, produces, and distributes various analog and digital imaging systems, and IT solutions for the printing industry and the healthcare sector, as well as for specific industrial applications worldwide. The company operates in three segments: Graphics, HealthCare, and Specialty Products. The Graphics segment offers integrated prepress solutions comprising consumables, hardware, software, and services for production workflow, project, and color management, as well as industrial inkjet printing solutions; and inks for various applications, such as documents, posters, banners, signage, displays, labels, and packaging materials. This segment also supplies digital proofing systems, large format printing, and the professional software that controls the prepress process; and digital inkjet printing presses for industrial applications. The HealthCare segment offers diagnostic imaging and healthcare IT solutions for hospitals and care centers. Its solutions and technologies include clinical information systems, hospital information systems, radiology information systems, picture archiving and communication systems, and imaging data centers, as well as systems for reporting, cardiology, decision support, clinical applications, data storage, direct radiography, computed radiography, X-ray films, and contrast media. The Specialty Products segment provides film-based products to business-to-business customers. This segment offers films for non-destructive testing, motion pictures, and aerial photography, as well as microfilms and films for the production of printed circuit boards. It also provides materials for high-security ID documents; conductive polymers; synthetic papers; and membranes for hydrogen production. The company markets its products through its own sales organization; and through a network of agents and representatives. Agfa-Gevaert NV was founded in 1867 and is headquartered in Mortsel, Belgium.

11,787 Employees
Last Reported Date: 04/12/13
Founded in 1867

agfa-gevaert nv (AGFB) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: €1.5M
Compensation as of Fiscal Year 2012.

agfa-gevaert nv (AGFB) Key Developments

Agfa-Gevaert N.V. Reports Consolidated Earnings Results for the First Quarter of 2013

Agfa-Gevaert N.V. reported consolidated earnings results for the first quarter of 2013. For the quarter, the company reported revenue of EUR 705 million compared to EUR 734 million reported a year ago. Recurring EBITDA was EUR 41 million compared to EUR 43 million reported a year ago. Recurring EBIT was EUR 21 million compared to EUR 21 million reported a year ago. Result from operating activities was EUR 12 million compared to EUR 11 million reported a year ago. Loss for the period was EUR 12 million compared to EUR 20 million reported a year ago. Net cash used in operating activities was EUR 36 million compared to EUR 7 million reported a year ago.

Agfa-Gevaert N.V., Q1 2013 Earnings Call, May 14, 2013

Agfa-Gevaert N.V., Q1 2013 Earnings Call, May 14, 2013

Agfa-Gevaert N.V. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Audited Consolidated Earnings Results for the Full Year Ended December 31, 2012

Agfa-Gevaert N.V. reported unaudited consolidated earnings results for the fourth quarter and audited consolidated earnings results for the full year ended December 31, 2012. For the quarter, the company reported revenue of EUR 812 million against EUR 805 million for the same period last year. Results from operating activities were EUR 37 million against loss from operating activities of EUR 12 million for the same period last year. Profit before income taxes was EUR 12 million against loss before income taxes of EUR 31 million for the same period last year. Recurring EBIT was EUR 57 million against EUR 43 million for the same period last year. Earnings per share were EUR 0.01 against loss per share of EUR 0.26 for the same period last year. Profit for the period was EUR 4 million against loss for the period of EUR 43 million for the same period last year. Net cash from operating activities was EUR 21 million against EUR 96 million for the same period last year. Acquisition of property, plant and equipment was EUR 13 million against EUR 19 million for the same period last year. For the year, the company reported revenue of EUR 3,091 million against EUR 3,023 million for the same period last year. Results from operating activities were EUR 96 million against EUR 36 million for the same period last year. Loss before income taxes was EUR 11 million against EUR 48 million for the same period last year. Recurring EBIT was EUR 139 million against EUR 129 million for the same period last year. Earnings per share were EUR 0.44 against loss per share of EUR 0.24 for the same period last year. Loss for the period was EUR 31 million against loss for the period of EUR 71 million for the same period last year. Net cash from operating activities was EUR 32 million against net cash used in operating activities of EUR 27 million for the same period last year. Acquisition of intangible assets was EUR 3 million against EUR 5 million for the same period last year. Acquisition of property, plant and equipment was EUR 41 million against EUR 55 million for the same period last year. Net financial debt amounted to EUR 291 million versus EUR 267 million at the end of 2011 and EUR 295 million at the end of the third quarter of 2012.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AGFB:BB €1.36 EUR -0.01

AGFB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Ellomay Capital Ltd $7.60 USD -0.1256
Fuji Pharma Co Ltd ¥2,142 JPY -29.00
Heidelberger Druckmaschinen AG €1.84 EUR -0.029
Merge Healthcare Inc $3.29 USD 0.00
Sectra AB kr51.50 SEK -0.50
View Industry Companies
 

Industry Analysis

AGFB

Industry Average

Valuation AGFB Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.1x
Price/Book 0.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AGFA-GEVAERT NV, please visit www.agfa.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.